Set the Course for a More Engaging & Productive Patient & Clinical Trial Site Journey
Discover how evolving clinical trial trends are reshaping patient and site experiences—and the steps sponsors can take to stay ahead—in this conversation with uMotif CEO Steve Rosenberg at SCOPE Summit 2025.
Sponsored by uMotif
In this video, uMotif CEO Steve Rosenberg discusses key trends shaping the clinical trial landscape, including CRO expansion, site network consolidation, and their impact on patients and sites. He explores how rising patient expectations for technologies like eCOA/ePRO and eConsent are driving industry progress and where gaps remain. Rosenberg also shares practical strategies for sponsors to strengthen patient-site relationships and explains how uMotif’s recent acquisition of ClinOne positions the company for future growth. Finally, he offers his forecast for the biggest changes ahead in clinical trials and how technology providers can prepare.
Watch and learn more:
• How evolving clinical trial requirements, site network consolidation, and CRO expansion are affecting patient and site experiences.
• Why patients increasingly expect clinical trial technologies (including eCOA/ePRO and eConsent) to be on par with the apps they use in daily life, and how the industry is making progress to meet these expectations.
• Concrete steps that sponsors can take today to enhance the patient-site relationship.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
